Alprazolam-Induced Hypomania

  title={Alprazolam-Induced Hypomania},
  author={J. Reddy and S. Khanna and U. Anand and A. Banerjee},
  journal={Australian and New Zealand Journal of Psychiatry},
  pages={550 - 552}
Objective: There are reports of alprazolam-induced hypomania/mania. Here is a case report of a patient who developed hypomania during treatment with alprazolam, but not with diazepam, another benzodiazepine derivative. Clinical picture: The illness was of 2 months' duration and the patient received a diagnosis of anxious depression. Following treatment with alprazolam, the patient developed hypomania characterised by euphoria, overactivity, overtalkativity, racing thoughts, oversocialisation… Expand
6 Citations
Les traitements adjuvants au cours de l’épisode maniaque
The clinical situations justifying the addition of an adjunct treatment during acute mania are described and the advantages and the inconveniences of combining antipsychotics and/or benzodiazepines with a mood stabilisers are clear up in order to define differentiated indications. Expand
Hypnotics and sedatives
A greater emphasis on objective, quantitative, and clinically relevant measures to assess the pharmacodynamic effects of these drugs is needed. Expand
Alcohol withdrawal delirium manifested by manic symptoms in an elderly patient
  • H. Chan, Kuan-I Lee
  • Psychology, Medicine
  • Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
  • 2015
A case involving a 63‐year‐old man who had alcohol withdrawal delirium that was manifested mainly by manic symptoms is reported, which is associated with significant morbidity and mortality. Expand
Bipolar disorder in women: reproductive events and treatment considerations
The main objectives are to assess the impact of reproductive events on the course of the disorder, and to discuss the relationships between reproductive events and psychiatric treatments. Expand
Alprazolam Kullanımına Bağlı Anksiyete Artışı
Anksiyete bozukluklari toplumda en yaygin gorulen, sosyal, mesleki ya da diger gunluk islevlerde kayiplara yol acan ruhsal bozukluklardir. Anksiyete semptomlarinin azaltilmasi amaciyla yaygin olarakExpand


Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
Alprazolam was found to be effective and well tolerated in patients with agoraphobia with panic attacks and panic disorder and significantly more placebo recipients subsequently dropped out of the trial, primarily citing ineffectiveness of placebo as the reason. Expand
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Treatment-related side effects that were worse in patients taking alprazolam than in those taking placebo included sedation, fatigue, ataxia, slurred speech, and amnesia, which tended to subside with dose reduction or continued administration of the drug. Expand
A case of alprazolam, but not lorazepam, inducing manic symptoms.
A patient developed manic symptoms during treatment with alprazolam, and subsequent administration of an equivalent dosage of lorazepam did not induce manic symptoms, suggesting the possibility of a novel benzodiazepine mechanism of action. Expand
Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines.
  • J. Cole, J. Kando
  • Psychology, Medicine
  • The Journal of clinical psychiatry
  • 1993
It appears that some differences between alprazolam and older benzodiazepines may exist, and worsening in post-traumatic stress disorder and an increase in impulsive behavior in patients with borderline personality disorder have only been reported in patients receiving alpazolam. Expand
Buspirone vs Alprazolam: A Double-Blind Comparative Study of Their Efficacy, Adverse Effects and Withdrawal Symptoms
Results of this study indicate a superiority of buspirone over alprazolam with regard to adverse effects and withdrawal symptoms. Expand
Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Alprazolam therapy was effective and well tolerated at a mean daily dose of 5.7 mg and Imipramine hydrochloride (175 mg/d) also produced significant panic relief but was associated with poor patient acceptance. Expand
Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
  • J. Cohn
  • Psychology, Medicine
  • The Journal of clinical psychiatry
  • 1981
Both alprazolam and diazepam were superior to placebo for the treatment of the clinical anxiety syndrome throughout a four-week double-blind multiclinic trial in 976 outpatients. At the fourth-weekExpand
Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
  • G. Klerman
  • Medicine
  • The British journal of psychiatry : the journal of mental science
  • 1992
The Cross-National Collaborative Panic Study, Phase Two, compared alprazolam with imipramine and with placebo in a sample of 1168 randomly assigned subjects, and both were superior to placebo for most outcome measures. Expand
Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine.
A 14-day treatment with adinazolam enhanced the responsiveness of rat hippocampal pyramidal neurons to microiontophoretically applied 5-HT but not to NE, and it is proposed that the antidepressant activity of adinAZolam might be mediated by a heightened 5- HT neurotransmission. Expand
Adverse behavioural events reported in patients taking alprazolam and other benzodinzepines
  • Journal of Clinical Psychiatry
  • 1993